Product Code: ETC13214013 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Veterinary CRO and CDMO Market was valued at USD 0.85 Billion in 2024 and is expected to reach USD 1.4 Billion by 2031, growing at a compound annual growth rate of 6.70% during the forecast period (2025-2031).
The Global Veterinary CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) Market is experiencing significant growth due to the increasing demand for specialized services in the animal health industry. These organizations provide a range of services including preclinical and clinical research, regulatory support, and manufacturing of veterinary pharmaceuticals. The market is driven by the rising prevalence of animal diseases, growing pet ownership, and the need for innovative and safe veterinary medicines. Key players in this market include Charles River Laboratories, Inc., Envigo, Covance, Inc., and Vetter Pharma International GmbH. As the veterinary industry continues to expand and evolve, the demand for CRO and CDMO services is expected to rise, presenting lucrative opportunities for market growth and development.
The Global Veterinary CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) market is experiencing significant growth due to the increasing demand for specialized services in the animal health industry. Key trends include the rising adoption of outsourcing services by veterinary pharmaceutical companies to streamline drug development processes and reduce time-to-market. Opportunities in this market lie in the development of innovative therapeutics for companion animals, livestock, and aquaculture, driven by the growing awareness of animal welfare and the need for effective treatments. Additionally, advancements in technology, such as personalized medicine and data analytics, are shaping the landscape of veterinary CRO and CDMO services, presenting avenues for expansion and collaboration within the industry. Overall, the market is poised for continued growth and innovation as the global focus on animal health and well-being continues to increase.
The Global Veterinary CRO and CDMO market faces challenges such as regulatory complexities related to animal health products, limited availability of skilled workforce with expertise in veterinary clinical trials and drug development, and the high cost of conducting research and development activities specifically for animal healthcare. Additionally, the market is highly fragmented with a mix of large multinational companies and small to medium-sized players, leading to intense competition and pricing pressures. Furthermore, the increasing demand for personalized veterinary medicine and the need for innovative solutions for emerging animal diseases pose additional challenges for companies operating in this market. Overall, navigating these challenges requires strategic partnerships, continuous innovation, and a deep understanding of the evolving regulatory landscape in the animal health industry.
The Global Veterinary CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) Market is primarily driven by the increasing demand for specialized services in animal health research and development. As pharmaceutical companies focus more on developing innovative veterinary drugs and therapies, they are outsourcing these services to CROs and CDMOs to benefit from their expertise and cost-effectiveness. Additionally, the rising prevalence of animal diseases and the growing awareness about the importance of animal healthcare are fueling the demand for veterinary CRO and CDMO services. The need for efficient and timely delivery of veterinary products, along with stringent regulatory requirements, is also propelling the market growth. Overall, the market is expected to expand further due to the increasing investments in research and development in the veterinary sector.
Government policies related to the Global Veterinary CRO and CDMO Market primarily focus on ensuring safety, efficacy, and quality in veterinary drug development and manufacturing processes. Regulatory bodies such as the FDA in the United States and the EMA in Europe have established guidelines and requirements that companies in the veterinary CRO and CDMO space must adhere to. These policies encompass areas such as Good Laboratory Practices (GLP), Good Clinical Practices (GCP), and Good Manufacturing Practices (GMP) to guarantee the integrity of research data, the ethical treatment of animals in studies, and the consistency and reliability of manufactured veterinary products. Additionally, government agencies often conduct inspections and audits to monitor compliance and enforce these regulations to safeguard animal health and welfare, as well as public health.
The Global Veterinary CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) Market is poised for significant growth in the coming years, driven by the increasing demand for specialized services in animal health research and development. The growing focus on animal welfare, the rising prevalence of zoonotic diseases, and the need for innovative veterinary medicines are expected to fuel the expansion of this market. Additionally, advancements in technology, such as genomics and personalized medicine, are likely to drive further opportunities for CROs and CDMOs in the veterinary sector. With the rising trend of outsourcing research and manufacturing activities to specialized service providers, the Global Veterinary CRO and CDMO Market is anticipated to experience steady growth and attract new players in the industry.
In the Global Veterinary CRO and CDMO market, North America holds the largest market share due to the presence of a well-established veterinary healthcare infrastructure and increasing pet ownership trends. Europe follows closely behind, driven by a growing focus on animal health and welfare. The Asia Pacific region is expected to witness significant growth in the coming years, attributed to the rising awareness about animal healthcare and the increasing demand for pharmaceutical services for companion animals. In the Middle East and Africa region, the market is poised for growth due to the expanding livestock sector and increasing investment in animal healthcare. Latin America is also showing promising growth opportunities, driven by the growing adoption of pets and increased expenditure on animal health services in the region.
Global Veterinary CRO and CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Veterinary CRO and CDMO Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Veterinary CRO and CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Global Veterinary CRO and CDMO Market - Industry Life Cycle |
3.4 Global Veterinary CRO and CDMO Market - Porter's Five Forces |
3.5 Global Veterinary CRO and CDMO Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Veterinary CRO and CDMO Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Veterinary CRO and CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Veterinary CRO and CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Veterinary CRO and CDMO Market Trends |
6 Global Veterinary CRO and CDMO Market, 2021 - 2031 |
6.1 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Contract Development &Manufacturing Organizations (CDMO), 2021 - 2031 |
6.1.3 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Contract Research Organizations (CRO), 2021 - 2031 |
6.2 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Medicines, 2021 - 2031 |
6.2.3 Global Veterinary CRO and CDMO Market, Revenues & Volume, By Medical Devices, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Veterinary CRO and CDMO Market, Overview & Analysis |
7.1 North America Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
7.2 North America Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Veterinary CRO and CDMO Market, Overview & Analysis |
8.1 Latin America (LATAM) Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Veterinary CRO and CDMO Market, Overview & Analysis |
9.1 Asia Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Veterinary CRO and CDMO Market, Overview & Analysis |
10.1 Africa Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Veterinary CRO and CDMO Market, Overview & Analysis |
11.1 Europe Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Veterinary CRO and CDMO Market, Overview & Analysis |
12.1 Middle East Veterinary CRO and CDMO Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Veterinary CRO and CDMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Veterinary CRO and CDMO Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Veterinary CRO and CDMO Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Veterinary CRO and CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Veterinary CRO and CDMO Market Key Performance Indicators |
14 Global Veterinary CRO and CDMO Market - Export/Import By Countries Assessment |
15 Global Veterinary CRO and CDMO Market - Opportunity Assessment |
15.1 Global Veterinary CRO and CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Veterinary CRO and CDMO Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Veterinary CRO and CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Veterinary CRO and CDMO Market - Competitive Landscape |
16.1 Global Veterinary CRO and CDMO Market Revenue Share, By Companies, 2024 |
16.2 Global Veterinary CRO and CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |